130 results
Page 5 of 7
F-4
5yit44e4
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
hh5t cxr73c
7 Jun 21
Prospectus supplement
9:16am
424B3
wd1mfa6
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
emkmv evt9i7b1eo0775
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
s1kxh4 wst7ok4vx8
3 Jun 21
Prospectus supplement
6:06am
424B3
fcv3daxf
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
wa36rb4j5yfvxcu0
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
0mu 2uwx7o
2 Jun 21
Prospectus supplement
10:10am
424B3
5hl ddnnk90hjq7ypul
2 Jun 21
Prospectus supplement
10:09am
424B3
mmaj1gr
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
3tkt8pdfgrpba
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
nsu66wtp
5 May 21
Business combination disclosure
5:27pm
425
22j8mlmt11k5i2xto3jg
5 May 21
Business combination disclosure
5:26pm
425
xi00tzysaplo0
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
9fthptmbwxr5n
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
zzrjnnf15
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
o4bnfxvtyucnsnpr8
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
xuf92sr
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
d29eqlgiew4d8iup ue
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
tgwzkeiuahp e4ajl91y
30 Apr 21
Annual report (foreign)
12:53pm